ZA90675B - Method for treating addiction to a drug of abuse employing an ace inhibitor - Google Patents

Method for treating addiction to a drug of abuse employing an ace inhibitor

Info

Publication number
ZA90675B
ZA90675B ZA90675A ZA90675A ZA90675B ZA 90675 B ZA90675 B ZA 90675B ZA 90675 A ZA90675 A ZA 90675A ZA 90675 A ZA90675 A ZA 90675A ZA 90675 B ZA90675 B ZA 90675B
Authority
ZA
South Africa
Prior art keywords
abuse
drug
employing
ace inhibitor
treating addiction
Prior art date
Application number
ZA90675A
Other languages
English (en)
Inventor
Zola Phillip Horovitz
Phillip Horovitz Zola
Abraham Sudilovksy
Sudilovksy Abraham
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of ZA90675B publication Critical patent/ZA90675B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA90675A 1989-01-30 1990-01-30 Method for treating addiction to a drug of abuse employing an ace inhibitor ZA90675B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/303,504 US5093129A (en) 1989-01-30 1989-01-30 Method for treating addiction to a drug of abuse employing an ace inhibitor

Publications (1)

Publication Number Publication Date
ZA90675B true ZA90675B (en) 1990-10-31

Family

ID=23172420

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA90675A ZA90675B (en) 1989-01-30 1990-01-30 Method for treating addiction to a drug of abuse employing an ace inhibitor

Country Status (10)

Country Link
US (1) US5093129A (xx)
EP (1) EP0381075A3 (xx)
JP (1) JPH02235822A (xx)
AU (1) AU630409B2 (xx)
CA (1) CA2007524A1 (xx)
HU (1) HUT53285A (xx)
IE (1) IE900313L (xx)
NZ (1) NZ232079A (xx)
PT (1) PT92988A (xx)
ZA (1) ZA90675B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2007525A1 (en) * 1989-01-30 1990-07-30 Zola P. Horovitz Method for facilating dieting employing an ace inhibitor
US5177064A (en) * 1990-07-13 1993-01-05 University Of Florida Targeted drug delivery via phosphonate derivatives
CA2050042A1 (en) * 1990-09-17 1992-03-18 Zola P. Horovitz Method for preventing or treating anxiety employing a combination of an ace inhibitor and a drug that acts at serotonin receptors
TW197945B (xx) * 1990-11-27 1993-01-11 Hoechst Ag
US6162802A (en) * 1992-03-10 2000-12-19 Papa; Joseph Synergistic combination therapy using benazepril and amlodipine for the treatment of cardiovascular disorders and compositions therefor
USRE39300E1 (en) 1993-01-28 2006-09-19 Virginia Commonwealth University Medical College Of Virginia Inhibiting the development of tolerance to and/or dependence on an addictive substance
US5321012A (en) * 1993-01-28 1994-06-14 Virginia Commonwealth University Medical College Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
DE4426259A1 (de) * 1994-07-25 1996-02-15 Upmeyer Hans Juergen Angiotensin-Converting-Enzym-Hemmer (ACE-Hemmer) Eine therapeutische Drogenentzugs-Alternative in der Behandlung Opiatabhängiger
US5824684A (en) * 1997-02-21 1998-10-20 Synapse Pharmaceuticals International, Inc. Method for treating drug and alcohol addiction
WO2004075893A1 (en) * 2003-02-24 2004-09-10 Diakron Pharmaceuticals, Inc. Method of treatment of cardiac and/or renal failure using a calcium channel blocker and an angiotensin converting enzyme inhibitor or an angiotensin ii receptor blocker
PL227900B1 (pl) 2012-11-15 2018-01-31 Adamed Spolka Z Ograniczona Odpowiedzialnoscia Kompozycja farmaceutyczna zawierająca inhibitor ACE i bloker kanałów wapniowych, sposób jej wytwarzania i jednostka dawkowania zawierająca tę kompozycję
CN110507652A (zh) * 2019-09-24 2019-11-29 中国医科大学 药物硝苯地平的新用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4046889A (en) * 1976-02-13 1977-09-06 E. R. Squibb & Sons, Inc. Azetidine-2-carboxylic acid derivatives
US4460604A (en) * 1976-06-03 1984-07-17 The Upjohn Company 4-Amino-4-aryl-cyclohexanones
US4416871A (en) * 1978-07-10 1983-11-22 The United States Of America As Represented By The Department Of Health And Human Services Inhibition by peptides of tolerance to and physical dependence on morphine
US4316906A (en) * 1978-08-11 1982-02-23 E. R. Squibb & Sons, Inc. Mercaptoacyl derivatives of substituted prolines
US4337201A (en) * 1980-12-04 1982-06-29 E. R. Squibb & Sons, Inc. Phosphinylalkanoyl substituted prolines
DK425582A (da) * 1981-09-25 1983-03-26 Wellcome Found Fremgangsmaade til fremstilling af amider
US4452790A (en) * 1982-06-23 1984-06-05 E. R. Squibb & Sons, Inc. Phosphonyl hydroxyacyl amino acid derivatives as antihypertensives
US4652641A (en) * 1984-06-26 1987-03-24 S. C. Mitri Benzofused lactams useful as antihypertensive agents and as cholecystokinin antagonists
DE3610391A1 (de) * 1986-03-27 1987-10-08 Hoechst Ag Verbindungen mit nootroper wirkung, diese enthaltende mittel und deren verwendung bei der behandlung und prophylaxe cognitiver dysfunktionen
FR2607004B1 (fr) * 1986-11-20 1990-06-01 Synthelabo Compositions pharmaceutiques contenant du diltiazem et un inhibiteur de l'enzyme de conversion de l'angiotensine
IL88502A (en) * 1987-12-14 1993-04-04 Squibb & Sons Inc Pharmaceutical compositions containing an angiotensin converting enzyme inhibitor

Also Published As

Publication number Publication date
JPH02235822A (ja) 1990-09-18
US5093129A (en) 1992-03-03
EP0381075A3 (en) 1992-12-09
PT92988A (pt) 1990-07-31
AU630409B2 (en) 1992-10-29
AU4851190A (en) 1990-08-02
HUT53285A (en) 1990-10-28
EP0381075A2 (en) 1990-08-08
HU9000380D0 (en) 1990-03-28
NZ232079A (en) 1997-06-24
IE900313L (en) 1990-07-30
CA2007524A1 (en) 1990-07-30

Similar Documents

Publication Publication Date Title
GB2227601B (en) Method of forming a micro-section
GB2216901B (en) Method of making camshaft
PH24321A (en) A method of treating hypercholesterolemia
HUT40142A (en) Process for producing peptidase inhibitors
EP0423836A3 (en) A method for dust-control treatment
GB9007821D0 (en) Method and apparatus for completion of a well
EP0409573A3 (en) Method of detecting positional deviation
ZA90675B (en) Method for treating addiction to a drug of abuse employing an ace inhibitor
EP0326516A3 (en) Method of making patterns
ZA896690B (en) Method of de-calcifying rare-earth metals formed by a reduction-diffusion process
EP0283666A3 (en) Method of treating photoresists
HU901814D0 (en) Process for producing inhibitors of aldose-reductase
EP0421478A3 (en) Method for immunochemical determination of hapten
GB2219082B (en) A method of identifying specific objects or zones
GB9024063D0 (en) A method of forming cards
GB2207368B (en) A method of treating containers
EP0313015A3 (en) A soil-stabilizing agent and a method for soil-stabilizing treatment
GB2227187B (en) Method of treatment of a substrate
EP0406002A3 (en) A method of surface treatment
GB8826916D0 (en) Method of knitting
ZA893363B (en) A method of identifying specific objects or zones
PL274012A1 (en) Method of purifying 6-methylene-5-hydroxytetracyclin hydrochloride
PL267488A3 (en) Method of purification of a polyvalent tripsinekalikrein inhibitor
PH24781A (en) A method of treating rheumatiodal arthritis
EG17856A (en) Method for treating drug addiction